Aug 21 (Reuters) – Pfizer Inc is in advanced talks
to acquire U.S. cancer drug company Medivation Inc for
close to $14 billion, as it seeks to boost its oncology
portfolio, a person familiar with the…
The post Pfizer nears $14 billion deal for Medivation-source appeared first on NASDAQ.